$2.89
-0.04 (-1.37%)
AVANIR Pharmaceuticals (NASDAQ:AVNR)
CAPS Rating:
A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.
A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.